Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.

Molecular biology reports

Volumn 39, Issue 12, 2012, Pages 10373-10382

  da Silva, Glenda Nicioli ^a   de Camargo, Elaine Aparecida ^b   Salvadori, Daisy Maria Favero ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CELL CYCLE PROTEIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; PROTEIN P53; TP53 PROTEIN, HUMAN; TRANSCRIPTOME;

ARTICLE; BLADDER TUMOR; CELL CYCLE; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 85027920874     PISSN: None     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1916-1     Document Type: Article

References (0)